Andesa Financial Management’s PDS Biotechnology PDSB Stock Holding History

Andesa Financial Management’s Portfolio PDSB Stock Details PDSB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	$76.9K	Buy	25,000 +12,500	+100%	+$102K	0.04%	122
2022 Q4	$165K	Sell	12,500 -12,500	-50%	-$88.2K	0.09%	140
2022 Q3	$74K	Buy	25,000 +12,500	+100%	+$53K	0.03%	151
2022 Q2	$46K	Hold	12,500	–	–	0.03%	133
2022 Q1	$77K	Buy	+12,500	New	+$77.6K	0.04%	147
2021 Q4	–	Sell	-16,655	Closed	-$248K	–	150
2021 Q3	$248K	Sell	16,655 -16,655	-50%	-$208K	0.13%	121
2021 Q2	$418K	Hold	33,310	–	–	0.13%	109
2021 Q1	$152K	Buy	33,310 +16,655	+100%	+$67K	0.05%	143
2020 Q4	$36K	Sell	16,655 -16,655	-50%	-$36.5K	0.02%	117
2020 Q3	$78K	Buy	33,310 +16,655	+100%	+$46.7K	0.03%	130
2020 Q2	$33K	Hold	16,655	–	–	0.03%	114
2020 Q1	$12K	Hold	16,655	–	–	0.01%	84
2019 Q4	$44K	Buy	+16,655	New	+$47.5K	0.04%	99

Other funds holding PDSB

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

EWA

EP Wealth Advisors Torrance, California $20.3B AUM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

IWA

Inspirion Wealth Advisors Libertyville, Illinois $874M AUM 16.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Andesa Financial Management's PDSB Position: Q1 2023 in Review

Andesa Financial Management increased its PDS Biotechnology (PDSB) stake by 100% in Q1 2023, buying an estimated $102K and bringing the position to 25,000 shares worth $76.9K. The position accounts for 0.04% of the portfolio, ranked #122.

Andesa Financial Management first reported a position in PDSB in Q4 2019 and has held it in 13 quarters since. The position peaked at $418K in Q2 2021. 68 funds tracked by Wall St. Rank hold PDSB as of Q1 2023.

Andesa Financial Management held 25,000 shares of PDS Biotechnology worth $76.9K as of Q1 2023.
Andesa Financial Management bought 12,500 PDS Biotechnology shares in Q1 2023, an estimated $102K.
PDS Biotechnology made up 0.04% of Andesa Financial Management's portfolio in Q1 2023, its #122 holding.
Andesa Financial Management first reported a position in PDS Biotechnology in Q4 2019 and has held it in 13 quarters since.
Andesa Financial Management's PDS Biotechnology position peaked at $418K in Q2 2021.
68 funds tracked by Wall St. Rank held PDS Biotechnology as of Q1 2023.

Based on Andesa Financial Management's 13F filing for Q1 2023, filed 5 May 2023.